EyePoint Pharmaceuticals Announces New Agreement for Expanded Access of DEXYCU® Within One of the Largest Integrated Delivery Systems in the U.S.
Dec 04, 2019
|
EyePoint Pharmaceuticals Announces Amendment to CRG Debt Facility
Nov 19, 2019
|
EyePoint Pharmaceuticals Appoints George O. Elston as Chief Financial Officer and Head of Corporate Development
Nov 14, 2019
|
EyePoint Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Corporate Progress
Nov 07, 2019
|
EyePoint Pharmaceuticals Announces Addition of DEXYCU® and YUTIQ® to Department of Veteran Affairs Federal Supply Schedule
Nov 04, 2019
|
EyePoint Pharmaceuticals Secures New Patient Access Agreement with Vizient Inc. for DEXYCU®
Nov 01, 2019
|
EyePoint Pharmaceuticals Announces Third Quarter 2019 Financial Results Release Date and Conference Call Information
Oct 24, 2019
|
EyePoint Pharmaceuticals Announces Permanent and Specific J-Code for YUTIQ® Now in Effect
Oct 02, 2019
|
EyePoint Pharmaceuticals Announces YUTIQ® Presentations at the American Academy of Ophthalmology 2019 Annual Meeting
Sep 27, 2019
|
EyePoint Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
Sep 26, 2019
|
EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ® to be Presented at the 52nd Annual Retina Society Scientific Meeting
Sep 09, 2019
|
EyePoint Pharmaceuticals Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress
Aug 07, 2019
|
EyePoint Pharmaceuticals Presents Positive Data Showcasing YUTIQ® at the 37th Annual Scientific Meeting of the American Society of Retina Specialists
Jul 30, 2019
|
EyePoint Pharmaceuticals Announces Early Assignment of Permanent and Specific J-Code J7314 for YUTIQ® by the Center for Medicare and Medicaid Services (CMS)
Jul 25, 2019
|
EyePoint Pharmaceuticals Announces Second Quarter 2019 Financial Results Release Date and Conference Call Information
Jul 24, 2019
|
EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ® to be Presented at the 37th Annual Scientific Meeting of the American Society of Retina Specialists
Jul 23, 2019
|
EyePoint Pharmaceuticals Appoints Wendy DiCicco, CPA, to Board of Directors
Jul 15, 2019
|
EyePoint Pharmaceuticals Added to Russell 3000® and 2000® Indexes
Jul 01, 2019
|
EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 13, 2019
|
EyePoint Pharmaceuticals Strengthens Executive Leadership Team with Key Hires
Jun 10, 2019
|